Literature DB >> 19023640

Aspirin thromboprophylaxis of asymptomatic antiphospholipid-positive subjects.

Monica Galli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19023640     DOI： 10.1007/s11739-008-0203-6

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  15 in total

Review 1.  Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome.

Authors:  Monica Galli; Davide Luciani; Guido Bertolini; Tiziano Barbui
Journal:  Blood       Date:  2003-06-19       Impact factor: 22.113

2.  Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? Yes (in some cases).

Authors:  Maria Gerosa; Cecilia Chighizola; Pier Luigi Meroni
Journal:  Intern Emerg Med       Date:  2008-07-01       Impact factor: 3.397

3.  The contribution of anti-prothrombin-antibodies to lupus anticoagulant activity--discrimination between functional and non-functional anti-prothrombin-antibodies.

Authors:  D A Horbach; E van Oort; R H Derksen; P G de Groot
Journal:  Thromb Haemost       Date:  1998-04       Impact factor: 5.249

4.  IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis.

Authors:  Bas de Laat; Ronald H W M Derksen; Rolf T Urbanus; Philip G de Groot
Journal:  Blood       Date:  2004-10-26       Impact factor: 22.113

5.  Hypercoagulability in centenarians: the paradox of successful aging.

Authors:  D Mari; P M Mannucci; R Coppola; B Bottasso; K A Bauer; R D Rosenberg
Journal:  Blood       Date:  1995-06-01       Impact factor: 22.113

6.  Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals.

Authors:  José A Girón-González; Enrique García del Río; Carmen Rodríguez; Javier Rodríguez-Martorell; Ascensión Serrano
Journal:  J Rheumatol       Date:  2004-08       Impact factor: 4.666

7.  beta2-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome.

Authors:  H Bas de Laat; Ronald H W M Derksen; Rolf T Urbanus; Mark Roest; Philip G de Groot
Journal:  Blood       Date:  2004-08-17       Impact factor: 22.113

8.  Lupus anticoagulant and anticardiolipin antibodies in an obstetric population.

Authors:  P Rix; J Stentoft; N A Aunsholt; M Dueholm; K A Tilma; M Høier-Madsen
Journal:  Acta Obstet Gynecol Scand       Date:  1992-12       Impact factor: 3.636

9.  A simple method to discriminate between beta2-glycoprotein I- and prothrombin-dependent lupus anticoagulants.

Authors:  M J A Simmelink; R H W M Derksen; J Arnout; P G De Groot
Journal:  J Thromb Haemost       Date:  2003-04       Impact factor: 5.824

10.  A prospective epidemiological study on the occurrence of antiphospholipid antibody: the Montpellier Antiphospholipid (MAP) Study.

Authors:  J F Schved; C Dupuy-Fons; C Biron; I Quére; C Janbon
Journal:  Haemostasis       Date:  1994 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.